These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6388720)

  • 1. Natural killer cells in renal allograft rejection.
    Cooksey G; Robins RA; Blamey RW
    Br J Surg; 1984 Nov; 71(11):874-7. PubMed ID: 6388720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of peripheral NK cell counts with Helios
    Trojan K; Zhu L; Aly M; Weimer R; Bulut N; Morath C; Opelz G; Daniel V
    Clin Exp Immunol; 2017 Jun; 188(3):467-479. PubMed ID: 28194759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
    Dos Santos DC; Campos EF; Saraiva Câmara NO; David DS; Malheiros DM
    Transpl Int; 2016 Apr; 29(4):443-52. PubMed ID: 26615051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer-cell activity in cyclosporine-treated renal allograft recipients.
    Lefkowitz M; Kornbluth J; Tomaszewski JE; Jorkasky DK
    J Clin Immunol; 1988 Mar; 8(2):121-7. PubMed ID: 2967307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer Cells Exhibit an Activated Phenotype in Peripheral Blood Mononuclear Cells of Renal Allograft Rejection Recipients: A Preliminary Study.
    Talebzadeh Bonakdar A; Mohammadi MM; Namdar A; Ahmadpoor P; Jafari D; Yekaninejad MS; Amirzargar AA
    Exp Clin Transplant; 2019 Aug; 17(4):490-497. PubMed ID: 31050618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OKT4/8 ratio in the blood and in the graft during episodes of human renal allograft rejection.
    von Willebrand E
    Cell Immunol; 1983 Apr; 77(1):196-201. PubMed ID: 6220816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection.
    Lefkowitz M; Jorkasky D; Kornbluth J
    Hum Immunol; 1987 Jun; 19(2):139-49. PubMed ID: 3301757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system.
    Hancock WW; Gee D; De Moerloose P; Rickles FR; Ewan VA; Atkins RC
    Transplantation; 1985 Apr; 39(4):430-8. PubMed ID: 3885494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activation in the lung allograft early posttransplantation.
    Meehan AC; Sullivan LC; Mifsud NA; Brooks AG; Snell GI; Kotsimbos TC; Westall GP
    Transplantation; 2010 Mar; 89(6):756-63. PubMed ID: 20019647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody.
    Kirkman RL; Araujo JL; Busch GJ; Carpenter CB; Milford EL; Reinherz EL; Schlossman SF; Strom TB; Tilney NL
    Transplantation; 1983 Dec; 36(6):620-6. PubMed ID: 6197792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
    Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation.
    Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT
    J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal anti-T12 antibody as therapy for renal allograft rejection.
    Carpenter CB; Milford EL; Reinherz EL; Schlossman SF; Tilney NL; Strom TB; Kirkman RL; Busch GJ; Araujo JL
    Trans Assoc Am Physicians; 1983; 96():84-92. PubMed ID: 6388105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of human renal allograft rejection and circulating K-cell, NK-cell, or total T-cell levels.
    Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lee HM; Mohanakumar T
    Clin Immunol Immunopathol; 1982 Dec; 25(3):335-47. PubMed ID: 6761023
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.